van Oostrum Anja, Zwaginga Jaap Jan, Croockewit Sandra, Overdevest Jacqueline, Fechter Mirjam, Ruiterkamp Bart, Brand Anneke, Netelenbos Tanja
Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands.
Centre for Clinical Transfusion Research, Sanquin, Leiden, The Netherlands.
J Clin Apher. 2017 Dec;32(6):397-404. doi: 10.1002/jca.21528. Epub 2017 Jan 31.
Peripheral blood stem cells (PBSCs) used for allogeneic transplantation are collected by apheresis after pre-treatment of donors with G-CSF. Using modern apheresis devices stem cells can be collected more efficiently. It was studied whether collection on the 4th instead of the 5th day after initiation of G-CSF treatment might be feasible. Stem cell yields that could have been collected on day 4 were calculated in two cohorts treated with 10 µg/kg G-CSF once daily (n = 106, cohort I) or 5 µg/kg twice daily schedule (n = 85, cohort II). Harvests were predicted using the median collection efficiency (CE) of the apheresis machine and regarded successful when > 5.0 x10 CD34 kg recipient body weight. Successful harvests at day 4 could have been obtained in only 22.6% and 41.2% of donors in cohort I and II respectively, while the expected successful collections on day 5 were 55.7% and 76.5%. Individual donor factors that correlated with a successful harvest on day 4 were weight, BMI, age, ratio donor/recipient weight and total G-CSF dose in cohort I, whereas ratio donor/recipient weight was the only significant predictor in cohort II. Donor weight, BMI and total G-CSF dose correlated positively with CD34 values in the blood on day 4 in all donors. However, donor characteristics were not able to be used as strong predictors in daily practice. In conclusion, PBSC collection on day 4 will not result in a successful harvest in most stem cell donors, however using a twice daily G-CSF scheme increases the yield.
用于异基因移植的外周血干细胞(PBSCs)是在供体接受粒细胞集落刺激因子(G-CSF)预处理后通过血细胞分离术采集的。使用现代血细胞分离设备可以更有效地采集干细胞。研究了在G-CSF治疗开始后的第4天而非第5天进行采集是否可行。在两个队列中计算了如果在第4天进行采集可能获得的干细胞产量,这两个队列分别接受每日一次10μg/kg G-CSF治疗(n = 106,队列I)或每日两次5μg/kg的给药方案(n = 85,队列II)。使用血细胞分离机的中位采集效率(CE)预测采集量,当采集量>5.0×10⁶ CD34⁺细胞/kg受体体重时视为成功采集。队列I和队列II中分别只有22.6%和41.2%的供体在第4天能够成功采集,而预计在第5天的成功采集率分别为55.7%和76.5%。在队列I中,与第4天成功采集相关的个体供体因素包括体重、体重指数(BMI)、年龄、供体/受体体重比和G-CSF总剂量,而在队列II中,供体/受体体重比是唯一显著的预测指标。在所有供体中,供体体重、BMI和G-CSF总剂量与第4天血液中的CD34⁺值呈正相关。然而,在日常实践中,供体特征不能作为强有力的预测指标。总之,对于大多数干细胞供体而言,在第4天采集PBSCs不会成功,但采用每日两次的G-CSF给药方案可提高采集量。